Insider Trading & Ownership of VIKING GLOBAL INVESTORS LP

Location
Stamford, CT
Summary
The estimated value of insider holdings of VIKING GLOBAL INVESTORS LP is at least $1,309,398,304 dollars as of 09 Oct 2025. VIKING GLOBAL INVESTORS LP is the 10%+ Owner of BridgeBio Pharma, Inc. and owns shares of BridgeBio Pharma, Inc. (BBIO) stock worth about $816.44M. VIKING GLOBAL INVESTORS LP is the 10%+ Owner of Roivant Sciences Ltd. and owns shares of Roivant Sciences Ltd. (ROIV) stock worth about $133.35M. VIKING GLOBAL INVESTORS LP is the 10%+ Owner of FIGS, Inc. and owns shares of FIGS, Inc. (FIGS) stock worth about $89.64M. VIKING GLOBAL INVESTORS LP is the 10%+ Owner of Ginkgo Bioworks Holdings, Inc. and owns shares of Ginkgo Bioworks Holdings, Inc. (DNA) stock worth about $79.39M. VIKING GLOBAL INVESTORS LP is the 10%+ Owner of 4D Molecular Therapeutics, Inc. and owns shares of 4D Molecular Therapeutics, Inc. (FDMT) stock worth about $78.2M. VIKING GLOBAL INVESTORS LP is the 10%+ Owner of STANDARD BIOTOOLS INC. and owns shares of STANDARD BIOTOOLS INC. (LAB) stock worth about $53.23M. VIKING GLOBAL INVESTORS LP is the 10%+ Owner of Amylyx Pharmaceuticals, Inc. and owns shares of Amylyx Pharmaceuticals, Inc. (AMLX) stock worth about $30.22M. VIKING GLOBAL INVESTORS LP is the 10%+ Owner of PROCEPT BioRobotics Corp and owns shares of PROCEPT BioRobotics Corp (PRCT) stock worth about $13.41M. VIKING GLOBAL INVESTORS LP is the 10%+ Owner of Frazier Lifesciences Acquisition Corp and owns shares of Frazier Lifesciences Acquisition Corp stock worth about $12.21M. VIKING GLOBAL INVESTORS LP is the 10%+ Owner of Inhibrx Biosciences, Inc. and owns shares of Inhibrx Biosciences, Inc. (INBX) stock worth about $3.32M.
Signature
/s/ Scott M. Hendler signing on behalf of O. Andreas Halvorsen (7)(8)
All Insider Reports
All Insider Reports

Notify me when VIKING GLOBAL INVESTORS LP files a new Insider Trading report.

⭐ Subscribe ⭐

Ownership of VIKING GLOBAL INVESTORS LP

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
BBIO BridgeBio Pharma, Inc. 10%+ Owner $816,436,500 -$154,000,000 -16% 27 Jun 2025
ROIV Roivant Sciences Ltd. 10%+ Owner $133,352,577 22 Jun 2023
FIGS FIGS, Inc. 10%+ Owner $89,635,549 02 Sep 2021
DNA, DNABW Ginkgo Bioworks Holdings, Inc. 10%+ Owner $79,390,749 02 Mar 2022
FDMT 4D Molecular Therapeutics, Inc. 10%+ Owner $78,195,176 04 Jan 2024
LAB STANDARD BIOTOOLS INC. 10%+ Owner $53,225,865 18 Mar 2024
AMLX Amylyx Pharmaceuticals, Inc. 10%+ Owner $30,222,333 08 Sep 2022
PRCT PROCEPT BioRobotics Corp 10%+ Owner $13,409,444 18 Mar 2022
FLAC Frazier Lifesciences Acquisition Corp 10%+ Owner $12,212,747 22 Nov 2022
INBX Inhibrx Biosciences, Inc. 10%+ Owner $3,317,364 -$11,287,500 -77% 07 Oct 2025
APG APi Group Corp 10%+ Owner $0 17 Jun 2024
INBX Inhibrx, Inc. 10%+ Owner $0 30 May 2024
RYZB RayzeBio, Inc. 10%+ Owner $0 26 Feb 2024
TIC, TICAW ACUREN CORP 10%+ Owner 14 Feb 2025
RLYB Rallybio Corp 10%+ Owner 15 Nov 2022

Insider Transactions Reported by VIKING GLOBAL INVESTORS LP:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.